THE SHAW PRIZE IN LIFE SCIENCE AND MEDICINE 2026
is awarded in equal shares to
ANNE DEJEAN
HUGUES DE THÉ
ZHU CHEN
for the discovery of the molecular and cellular bases of acute promyelocytic leukemia and the pioneering of a synergistic targeted therapy that transformed the disease from one of the most deadly to one of the most curable cancers.
27 May 2026
